Clinical Trial: Safety and Efficacy of CC-10004 for Prurigo Nodularis

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: An Open Label, Single Center Study to Assess the Safety and Efficacy of a 24 Week Treatment Course of CC-10004 in Adults With Recalcitrant Nodularis

Brief Summary:

This trial will include:

  • Study period up to 7 months.
  • Office visits monthly lasting approximately 1 hour.
  • Blood Draws.
  • Oral medication that is taken 2 times daily.
  • Photographs and biopsies if agreed.

Detailed Summary:
Sponsor: University Hospitals Cleveland Medical Center

Current Primary Outcome: Improvement in Prurigo Nodularis [ Time Frame: 24 weeks ]

Original Primary Outcome: Determine the effect on patient pruritus as measure by the Visual Analog Scale for Prurtis [ Time Frame: 12 weeks ]

Current Secondary Outcome:

Original Secondary Outcome:

Information By: University Hospitals Cleveland Medical Center

Dates:
Date Received: March 23, 2009
Date Started: September 2008
Date Completion:
Last Updated: September 27, 2016
Last Verified: September 2016